Evidence map›Paper›PMID 40960600›Full record

ReviewIntensive care medicine2025

Echocardiography guided management of atrial fibrillation.

M Balik, P Vignon, M S Chew, G Tavazzi, P Mayo, G Doufle, J Aron, J Hastings, B Cholley, K Jiroutkova and 3 more

Abstract readReview
In one paragraph

Review in Intensive care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

M BalikFirst Faculty of Medicine, Department of Anesthesiology and Intensive Care, Charles University and General University Hospital, Prague, Czechia. martin.balik@vfn.cz.ORCID 0000-0003-1864-2143
P VignonMedical-Surgical ICU and Inserm CIC 1435, Dupuytren Teaching Hospital, Limoges, France.
M S ChewDepartment of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
G TavazziDepartment of Intensive Care, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
P MayoLIJ/NSUH Division of Pulmonary, Critical Care, and Sleep Medicine, Donald and Barbara School of Medicine at Northwell/Hofstra, Hempstead, NY, USA.
G DoufleDepartment of Anesthesia and Pain Management, Interdepartmental Division of Critical Care Medicine, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
J AronCritical Care Department, St Georges University Hospital, London, UK.
J HastingsDepartment of Anaesthesiology and Critical Care Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
B CholleyDepartment of Anaesthesiology, Critical Care and Perioperative Medicine, Hopital Européen Georges Pompidou, AP-HP, and Université Paris Cité, Paris, France.
K JiroutkovaThird Faculty of Medicine, Department of Anaesthesiology and Intensive Care, Charles University, Prague, Czechia.
M SlamaMedical Intensive Care Unit, Amiens University Hospital, Amiens, France.
A HerpainDepartment of Intensive Care, Saint-Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
A McLeanNepean Clinical School, Sydney Medical School, University of Sydney, Sydney, Australia.

Funding

Ministerstvo Zdravotnictví Ceské Republiky supported from MH CZ-DRO 0064165
6 · The paper itself

Abstract

backgroundThe growing burden of atrial fibrillation (AF) experienced by the general population translates into an increased incidence in the intensive care setting, further aggravated by illness severity. New onset AF has been established as an independent mortality predictor. Cardiology management guidelines are based on major trials that included ambulatory patients with varying degrees of ventricular systolic and diastolic dysfunction, and with variable dependences of left ventricular filling on atrial systole. Emphasis is placed on rate control combined with anticoagulation therapy, along with careful consideration of limiting any myocardial depression by antiarrhythmic medication in patients who often already have some form of structural heart disease.

designNarrative review Objectives: Critical care echocardiography (CCE) is well established as a widely available diagnostic and monitoring tool in haemodynamically unstable patients. It assists in identifying risk factors associated with arrhythmias, reveals parameters associated with arrhythmia chronicity, and guides therapy to facilitate a return to sinus rhythm. CCE helps guide the crucial management decision to seek either rhythm or rate control and, with rhythm control, monitors return of mechanical sinus rhythm with left atrial recovery post cardioversion. Echocardiography can also help when conflicting management goals are present, such as guideline-driven therapeutic anticoagulation in the intensive care patient that is at significant risk of bleeding.

resultsThis review seeks to assist intensive care practitioners managing patients with AF, with a focus on the many benefits CCE offers, blending specific intensive care medicine data to current cardiology guidelines on arrhythmia management in these severely ill patients.

Indexed as

Atrial FibrillationCritical CareEchocardiographyAnti-Arrhythmia AgentsAnticoagulantsHumansAnti-Arrhythmia AgentsAnticoagulantsAtrial fibrillationCardioversionEchocardiographyRate controlRhythm controlSupraventricular arrhythmia

Identifiers

PMID40960600
PMCPMC12504342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.